SCM
Suvretta Capital Management Portfolio holdings
AUM
$4.01B
1-Year Est. Return
66.2%
This Fund
S&P 500
1 Year Est. Return
+66.2%
AUM
$3.3B
AUM Growth
+$644M
(+24%)
Holding
106
Top Buys
| 1 | +$49.2M | |
| 2 | +$31.6M | |
| 3 | +$30.3M | |
| 4 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
+$28.2M |
| 5 |
Ferguson
FERG
|
+$26.4M |
Top Sells
| 1 | +$60.4M | |
| 2 | +$39.4M | |
| 3 | +$28.8M | |
| 4 |
Datadog
DDOG
|
+$24M |
| 5 |
Arcutis Biotherapeutics
ARQT
|
+$16.7M |
Sector Composition
| 1 | Healthcare | 60.44% |
| 2 | Technology | 13.51% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVLA
26
Palvella Therapeutics
PVLA
$1.56B
| $51.6M | 1.56% |
822,400
+107,937
|
|
||
27
Capital One
COF
$122B
| $50.8M | 1.54% |
238,770
+44,610
|
|
||
28
Danaher
DHR
$145B
| $50.7M | 1.54% |
255,800
+81,100
|
|
||
29
Arcus Biosciences
RCUS
$2.81B
| $50.2M | 1.52% |
3,688,858
|
|
||
30
Fulcrum Therapeutics
FULC
$556M
| $49.5M | 1.5% |
5,381,000
+298,100
|
|
||
31
Compass Therapeutics
CMPX
$1.01B
| $49.4M | 1.5% |
14,101,159
+6,951,666
|
|
||
32
Amazon
AMZN
$2.33T
| $48M | 1.45% |
218,547
-39,078
|
|
||
33
Tesla
TSLA
$1.52T
| $40.6M | 1.23% |
91,252
-1,105
|
|
||
34
Keurig Dr Pepper
KDP
$39.2B
| $40.1M | 1.21% |
+1,570,000
|
|
||
35
Boston Scientific
BSX
$107B
| $34.5M | 1.05% |
353,561
|
|
||
|
36
AdvisorShares Pure US Cannabis ETF
MSOS
$778M
| $34.3M | 1.04% |
+7,167,000
|
|
||
37
UnitedHealth
UNH
$264B
| $33.2M | 1.01% |
96,220
+28,220
|
|
||
|
RNAM
38
DELISTED
Avidity Biosciences
RNAM
| $32.7M | 0.99% |
+750,000
|
|
||
39
Erasca
ERAS
$4.68B
| $31.6M | 0.96% |
14,502,004
|
|
||
40
Insmed
INSM
$32.3B
| $31.4M | 0.95% |
217,783
-21,000
|
|
||
41
ProKidney
PROK
$348M
| $29.9M | 0.91% |
12,341,266
|
|
||
42
Salesforce
CRM
$181B
| $29.7M | 0.9% |
+125,250
|
|
||
43
Dick's Sporting Goods
DKS
$18B
| $28.5M | 0.86% |
128,290
-132,175
|
|
||
44
Aura Biosciences
AURA
$396M
| $27M | 0.82% |
4,372,884
|
|
||
45
Monte Rosa Therapeutics
GLUE
$1.42B
| $24.9M | 0.75% |
3,360,000
|
|
||
46
Johnson & Johnson
JNJ
$591B
| $24.6M | 0.75% |
132,786
|
|
||
47
Zura Bio
ZURA
$663M
| $23.7M | 0.72% |
5,472,891
+611,952
|
|
||
48
Biogen
BIIB
$27B
| $23.6M | 0.71% |
168,190
+16,300
|
|
||
49
Marvell Technology
MRVL
$68.2B
| $22.9M | 0.69% |
+272,300
|
|
||
50
ServiceNow
NOW
$119B
| $20.2M | 0.61% |
+110,000
|
|